Microfluidics Market will register a CAGR of 14.4% through 2026 - PowerPoint PPT Presentation

View by Category
About This Presentation

Microfluidics Market will register a CAGR of 14.4% through 2026


With 14.5% CAGR, point of care testing segment is the largest segment among the global microfluidics market application segments By the end of 2026, the point of care testing segment is projected to reach more than US$ 3,000 Mn in revenue and is estimated to grow 3.9x by 2026 end as compared to that in 2016. The point of care testing segment is the largest segment among the different application segments in the global microfluidics market, which was estimated to create close to US$ 1,000 Mn or 33.2% share of the total market in 2016. This segment is anticipated to register a CAGR of 14.5% over the forecast period. – PowerPoint PPT presentation

Number of Views:2


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Microfluidics Market will register a CAGR of 14.4% through 2026

Cytomegalovirus Treatment Market to be valued at
US 145.5 Mn by 2028
  • Healthcare, Pharmaceuticals Medical Devices
  • January 2019

Report Id REP-GB-8665 Status Publish Category
Healthcare, Pharmaceuticals Medical Devices
AboutFuture Market Insights
Future Market Insights (FMI) is a premier
provider of syndicated research reports, custom
research reports, and consulting services. We
deliver a complete packaged solution, which
combines current market intelligence, statistical
anecdotes, technology inputs, valuable growth
insights, aerial view of the competitive
framework, and future market trends. We provide
research services at a global as well as regional
level key regions include GCC, ASEAN,
and BRIC. Our offerings cover a broad spectrum of
industries including Chemicals, Materials,
Energy, Technology, Healthcare, and Retail. We
have a global presence with delivery centers
across India specializing in providing global
research reports and country research reports.
FMI is headquartered out of London, U.K., with a
state-of-the-art delivery center located in Pune,
India. We combine our knowledge and learning from
every corner of the world to distill it to one
thing the perfect solution for our client.
Research Capabilities
Sector Coverage
  • Customized Research
  • Syndicated Research
  • Investment Research
  • Social Media Research

  • Automotive and Transportation
  • Electronics, Semiconductor, and ICT
  • Retail and Consumer Products
  • Industrial Automation and Equipment
  • Chemicals Materials
  • Food and Beverages
  • Services and Utilities
  • Energy, Mining, Oil, and Gas

Subscription Information

For detailed subscription information please
contact Hari. T (Sr. Manager - Global Business
Development) T 44 (0) 20 7692 8790 D 44
20 3287 4268 Email hari.t_at_futuremarketinsights.co
Research Methodology (1/2)
  • Systematic Research Approach

In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc.
PMR formulates a detailed discussion guide to conduct expert and industry interviews
PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts
PMR conducts interviews with industry experts, industry players, distributors and retailers
Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data
Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry
PMR delivers industry insights and information in the required format (PDF)
  • Identifying key opinion leaders
  • Questionnaire design
  • In-depth interviews
  • Coverage across value chain
  • Key industry experts
  • Channel study
  • Developments
  • Market dynamics
  • Products
  • Conclusions

  • Market participants
  • Key strengths
  • Product portfolio
  • Mapping as per value chain
  • Key focus segments

Primary Research
Secondary Research
Paid Publications
  • Linkedin
  • Zoominfo
  • Salesforce
  • Avention
  • Factiva
  • GBI
  • Genios
  • Meltwater
  • Company websites
  • Company annual reports
  • White papers
  • Financial reports

includes sources of databases
Cytomegalovirus Treatment Market Analysis
  • A new study by the company, titled '
    Cytomegalovirus Treatment Market Global Industry
    Analysis 2013-2017 and Opportunity Assessment
    2018-2028,' points out the key structural outlook
    for the cytomegalovirus treatment market. A large
    number of people are infected by Cytomegalovirus
    (CMV) virus during their life course, mostly in
    indications that are invasively treated like
    organ transplantation and stem cell
    transplantation. The virus is found active post
    treatment or later stages of any other treatment
    like mentioned before. Cytomegaloviruses are
    among the most prevalent viral infections present
    on a global level. Transmission of such
    cytomegalovirus occurs via direct contact with
    the infected person or infected secretions.
    Cytomegalovirus treatment requires drug in
    correct stage of activation of the virus. The
    presence of this virus is very common, but the
    activation requires different mediums and time of
    breeding. There are many indications related to
    cytomegalovirus conditions like organ
    transplantation, AIDS, congenital CMV and most
    recent stem cell transplantations
  • Infants can get infected by this cytomegalovirus
    in utero. A major portion of prevalent population
    comes out to be infants, congenital
    cytomegalovirus estimates to account for a great
    number of cases which is mostly observed in
    developed countries like the U.S. Being
    asymptomatic at birth it is likely ignored for
    having a cytomegalovirus treatment and cause some
    serious health issues. Cytomegalovirus is
    responsible for a number health disorders in
    infants like hearing disorders, seizures, rashes
    and SNHL
  • Request Sample Report_at_ https//www.futuremarketins

Cytomegalovirus Treatment Market Analysis
  • The market for cytomegalovirus treatment is
    primarily based on off-label drugs prescription.
    As the condition is either treated by some
    therapeutic relief or preventive measures before
    its activation in blood cells. There are some
    major drug types that are being used for
    cytomegalovirus treatment, though primarily
    antiviral drug class is used for such condition.
    Valcyte (Valganciclovir hydrochloride)
    manufactured by Roche is one of the rare branded
    drugs available for cytomegalovirus treatment.
    Aside from such medications most of the
    cytomegalovirus treatment market is driven by
    generic drugs such as foscarnet and ganciclovir.
    CMV-IG, is a biologic which is available in the
    US market since 1992. And most of the drug
    including valacyclovir and acyclovir are used
    off-label for cytomegalovirus treatment. A
    dynamic nature of drug approval process can also
    limit some drugs which are expected to provide
    good revenue share to the cytomegalovirus
    treatment market.
  • The market for cytomegalovirus treatment hence
    leaves a greater untapped opportunities for
    manufacturers to a come with a technology solely
    for cytomegalovirus condition. It would not only
    assure a good fortune turn for the company but
    would also drastically effect the cytomegalovirus
    treatment market.
  • The development present for cytomegalovirus
    treatment is progressive, with many molecules in
    various stages of clinical development. There are
    more than 350 clinical trials being performed for
    cytomegalovirus treatment all around the globe.
    Europe and North America accounts for the highest
    number of registered clinical trials for
    cytomegalovirus treatment. Late-stage pipeline
    consists of exceptional drugs which are expected
    to enter the market within the forecast period
    and is presumed to have a positive outlook in the
    global cytomegalovirus treatment market.

Cytomegalovirus Treatment Market Analysis
  • The global cytomegalovirus treatment market
    revenue is inclined towards the developed regions
    of North America and parts of Latin America. With
    rise in awareness for cytomegalovirus treatment,
    and increase in number of parallel combinations,
    the cytomegalovirus treatment market is estimated
    to rise with a positive CAGR over the period of
    forecast. Greater number of drugs for
    cytomegalovirus treatment are in pipeline phase.
    And in coming few years the number of sole drugs
    for cytomegalovirus treatment is going to rise,
    presently the trend is towards adopting off-label
    drugs. Key companies analyzed for cytomegalovirus
    treatment market which provides a selection of
    drugs include Merck Co. Inc., Mylan N.V.,
    Chimerix, Inc., Thermo Fisher Scientific, Abbott,
    Becton, Dickinson and Company, Johnson Johnson,
    Bio-Rad Laboratories Inc., F. Hoffmann-La Roche
    Ltd and Pfizer.
  • Request to View Methodology _at_ https//www.futurema

To know more about us, please visit our website
www.futuremarketinsights.com For sales queries
or new topics email us on sales_at_futuremarketinsi
ghts.com For media queries, contact the press
office at press_at_futuremarketinsights.com For
other queries contactHari. T (Sr. Manager -
Global Business Development) Future Market
Insights 3rd Floor,207 Regent Street, London
W1B 3HH T 44 20 7692 8790 D 44 20 3287
4268 Email hari.t_at_futuremarketinsights.com
Thank You
Future Market Insights Global Consulting
Private Limited (FMI)
About PowerShow.com